Potsdam, Germany

Kerstin Kaufmann

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Basf Se Corporation, Bayer Cropscience Nv. Active years: 2019-2022.


% Patents Active = 100.0

 

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2019-2022

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kerstin Kaufmann: Innovator in Plant Modulation

Introduction

Kerstin Kaufmann is a prominent inventor based in Potsdam, Germany. She has made significant contributions to the field of plant science, particularly in the modulation of flowering time in monocot plants. With a total of 2 patents, her work has implications for agriculture and crop development.

Latest Patents

Kerstin's latest patents focus on methods and means for modulating flowering time in monocot plants. The inventions relate to the identification of monocot FLC sequences, such as wheat FLC sequences, and their uses in modulating flowering time, seed development, and seed germination. These advancements are crucial for improving crop yields and ensuring food security.

Career Highlights

Throughout her career, Kerstin has worked with notable companies in the agricultural sector, including BASF SE and Bayer CropScience NV. Her experience in these organizations has allowed her to apply her innovative ideas in practical settings, contributing to advancements in crop science.

Collaborations

Kerstin has collaborated with esteemed colleagues such as Philip Ruelens and Koen Geuten. These partnerships have fostered a collaborative environment that enhances research and development in her field.

Conclusion

Kerstin Kaufmann is a trailblazer in the field of plant modulation, with her patents paving the way for future innovations in agriculture. Her work exemplifies the importance of scientific research in addressing global challenges related to food production.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…